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Abstract Purpose: To describe
trends in pediatric home mechanical
ventilation (HMV) and their impact
on the use of pediatric intensive care
unit (PICU) beds. Methods: Review
of all children who had started HMV
in a single center for HMV.
Results: Between 1979 and 2009,
HMV was started in 197 patients [100
(51 %) with invasive and 97 with
noninvasive ventilation], with a
median age of 14.7 (range 0.5–17.9)
years. Most patients (77 %) were
males with a neuromuscular disorder
(66 %). The number of children
receiving HMV increased from 8 in
the 1979–1988 period to 122 in the
1999–2008 period. This increase
occurred foremost in patients aged
0–5 years and was accompanied by a
sharp rise in the use of PICU beds. In
150 patients (76 %), HMV was initi-
ated on an ICU with a total of 12,440
admission days, of which 10,385 days
(83 %) could be attributed to 67
patients who started non-electively
with invasive HMV. Of the latter, 52
patients had been admitted to a PICU
with a total of 9,335 admission days.
At the end of the study, 134 patients
(68 %) were still being ventilated, 43
patients (22 %) had died, 11 patients
(6 %) were weaned from HMV, 4
patients (2 %) did not want to con-
tinue HMV and 5 patients (3 %) were
lost to follow-up. Conclu-
sions: Over time, there was an
impressive increase in the application
of HMV in children. This increase
was most obvious in the youngest age
group with invasive HMV, and these
children had very long stays in the
PICU.
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Introduction
In patients with chronic respiratory failure the aims of
home mechanical ventilation (HMV) include prolonging
life, while maintaining or improving the quality of life,
and reducing morbidity [1–6]. In the past decades the
number of adults that beneﬁtted from HMV seems to have
increased steadily. This growth may be explained by the
immense success of HMV and thus a greater awareness
among physicians and patients; improvements in tech-
nology and medical care; and by an increased patient
autonomy and a different moral-ethical attitude with
respect to treatment decisions. In agreement with the
trend in adults, we got the impression that HMV was also
being applied in children more often, at an increasingly
younger age, and also for less ‘classical’ diseases.
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Given these changes, we were interested in their possible
impact on the use of pediatric intensive care beds. With the
improvements that had been realized over the years with
regard to discharge planning, we were particularly inter-
ested in the length of stay following the initiation of HMV
in the pediatric intensive care unit (PICU). The goals of
this study were therefore to describe [1] the experiences
and changes in applying HMV in children and [2] the
impact of these changes on the use of PICU beds.
Patients and methods
The study was designed as a retrospective, single-center
observational study in the Center for HMV Utrecht, which
is part of the University Medical Center Utrecht and one
of the four HMV Centers in the Netherlands. The need for
institutional review board approval was waived.
Patients and setting
All patients who had started HMV before the age of 18
before 1 January 2009 were included. The standard oper-
ating procedure for HMV in our Center is that children
undergo an intake, either during a visit at the outpatient
clinic or in the hospital where they have been admitted.
HMVcanthenbeinitiatedafterallrequiredinformationhas
been given and with mutual and thoughtful agreement of
the patient, family and medical team of the Center for
HMV.Generally,HMVistheninitiatedwhenpatientshave
clinical manifestations of (nocturnal) hypoventilation
together with (nocturnal) hypercapnia (PaCO2[45.0
mmHg or 6.0 kPa). The presence of hypercapnia could be
established in a (P)ICU, a hospital ward, or a specially
designatedrespiratorycareunit(whichstartedoffin1997),
mainly depending on the child’s age and clinical circum-
stances. The setup of HMV was regarded as elective if
clinicallystablepatientshadbeenadmittedonbehalfofthe
Center for HMV because of suspected nocturnal or proven
(diurnal)ventilatoryfailure.Inpatientswhowereunknown
to the Center for HMV before admission to an ICU or in
patients known to the Center for HMV who had an
unforeseenadmissiontoanICU,theinitiationofHMVwas
regarded as non-elective.
Setting up HMV was a joint action of the nurses and
physicians of the Center for HMV and the ward where the
patient was admitted. Discharge planning was a multi-
disciplinary effort, which was coordinated by a nurse of
the Center for HMV. Funding, training and the provision
of equipment never caused a problem, but housing, family
issues and particularly recruitment of competent profes-
sionals sometimes did. Following discharge, the Center
for HMV took care of patients by supplying all necessary
equipment and materials, regular and intermittent home
visits, continuous accessibility and continuous education
of all persons involved in the care of these patients. In
case of medical problems not related to HMV, patients
were seen by their general practitioner and primarily
referred to a local hospital, if needed.
Data collection and deﬁnitions
Demographicandclinicaldataofpatientswereretrievedfrom
their medical records. The underlying diseases were divided
into four categories: neuromuscular disorders (like spinal
muscular atrophy, Duchenne muscular dystrophy), central
nervous system diseases (like Arnold Chiari malformation,
congenital central hypoventilation syndrome), airway dis-
eases (like bronchopulmonary dysplasia, cystic ﬁbrosis) and
miscellaneous diseases (like congenital scoliosis). The chil-
dren were divided into three age groups (0–5, 6–11 and
12–17 years) and 3 decades (1979–1988, 1989–1998 and
1999–2008) in which their HMV was initiated.
Speciﬁc data from PICU admissions were noted: day
of admission to the PICU, the day that ventilation with a
home care ventilator was started and the day patients were
discharged from the PICU. The numbers of days in the
PICU before and following initiation of ventilation with a
home care ventilator are referred to as the pre- and post-
HMV period, respectively.
Results
Between 1 January 1979 and 1 January 2009, 197 chil-
dren had started with HMV (Table 1). HMV was started
at a median age of 14.7 years (range 0.5–17.9 years).
Most patients (63 %) were between 12 and 18 years when
HMV was started, and most of them were males with a
neuromuscular disorder. Invasive HMV was started in
100 patients. We observed that over the 3 decades the
percentage of invasive ventilation decreased from 100 to
39 %. In 108 patients (55 %) HMV was started non-
electively. This occurred most often in the youngest age
group, and most of these patients required invasive
mechanical ventilation. Patients in the youngest age group
had various underlying diseases (Table 1).
Atthe end ofthe study,patients hadbeen onHMVfora
median of 5.6 years (range 0–29.8 years). On 1 January
2009, 134 patients (68 %) were still actively ventilated, 43
patients (22 %) had died, 11 patients (6 %) were weaned
from HMV, including 4 patients with cystic ﬁbrosis who
underwent a lung transplant, 4 patients (2 %) did not want
to continue HMV and 5 patients (3 %) were lost to follow-
up (Fig. 1). The characteristics of the 43 patients who died
arepresentedinTable 2.Themostcommoncausesofdeath
were cardiac (n = 15; mostly Duchenne patients) or chest
848infection (n = 5). Two patients died after accidental
decannulation.
Changes over time
Overtheyears,therewasasubstantialincreaseinthenumber
of children receiving HMV (Fig. 2). During the 1979–1988
period, only 8 patients received HMV (all invasive, see
Table 1), and this increased to 122 in the 1999–2008 period
[of whom 47 (39 %) started with invasive HMV, see
Table 1].Comparingthedifferentagegroupswithrespectto
receiving HMV, we noticed a 1.5-fold increase in older
children (12–17 years), a 2-fold increase in children aged
6–11 years and a 3-fold increase in the youngest children
(0–5 years) over the last 10 years in comparison to the pre-
ceding 10 years, respectively (Fig. 2). Over the years, the
proportionofpatientswhostartedwithHMVnon-electively
slightly decreased from 75 % (6 out of 8 patients) in the
1979–1988 period to 56 % (68 out of 122 patients) in the
1999–2008 period, respectively.
Table 1 Characteristics of all children who started home mechanical ventilation (HMV) before the age of 18 years, between 1 January
1979 and 1 January 2009
Age of HMV onset
All patients 0–5 years 6–11 years 12–17 years
n = 197 n = 41 n = 32 n = 124
Demographic data
Median age (years) onset HMV 14.7 (0.5–17.9) 1.5 (0.5–5.5) 9.5 (6–12) 15.9 (12–17.9)
Male/female (%) 77/23 63/37 66/34 85/15
Median time of follow-up (years) 5.6 (0–29.8) 2.9 (0–26.2) 7.2 (0.5–29.8) 6.3 (0–25.2)
Underlying diseases (n,% )
Neuromuscular disorders 130 (66) 14 (34) 18 (56) 98 (79)
Central nervous system disorders 33 (17) 12 (29) 8 (25) 13 (10)
Chronic pulmonary or airway diseases 13 (6) 7 (17) 1 (3) 5 (4)
Miscellaneous 21 (11) 8 (20) 5 (16) 8 (7)
Indication (n,% )
Non-elective (all patients) 108/197 (55)
a 35/41 (85) 13/32 (41) 60/124 (48)
1979–1988 6/8 (75) 1/1 (100) 1/2 (50) 4/5 (80)
1989–1998 34/67 (51) 8/10 (80) 6/10 (60) 20/47 (43)
1999–2008 68/122 (56) 26/30 (87) 6/20 (30) 36/72 (50)
Start HMV, type of support (n,% )
Invasive ventilation (all patients) 100/197 (51) 31/41 (76) 11/32 (34) 58/124 (47)
1979–1988 8/8 (100) 1/1 (100) 2/2 (100) 5/5 (100)
1989–1998 45/67 (67) 8/10 (80) 7/10 (70) 30/47 (64)
1999–2008 47/122 (39) 22/30 (73) 2/20 (10) 23/72 (32)
Ventilator dependency at end of study n = 134 n = 29 n = 25 n = 80
Nocturnal ventilation only (%) 46 55 64 36
Ventilation during 8–20 h/day (%) 17 28 20 13
Ventilation 20–24 h/day (%) 37 17 16 51
a Number and percentage (between brackets) of relevant cases per (sub) group for that particular decennium and age group
Fig. 1 Flow diagram
summarizing the outcome of
children who started HMV
before the age of 18 years
between 1979 and 2009
849PICU length of stay
In 150 patients (76 %), HMV was initiated in an ICU. The
total number of admission days was 12,440. The majority
of the admission days, namely 10,385 (83 %), could be
attributed to 67 patients who started invasive HMV non-
electively. Of these 67 patients, 52 had been admitted to a
PICU with a total number of 9,335 admission days.
Considering this observation, a sub-analysis was per-
formed of the PICU length of stay in this last category of
patients: it was further divided in pre-HMV and post-
HMV days over the 3 decades. The results of this analysis
are given in Table 3. The total PICU length of stay
increased considerably over the 3 decades. This was
attributed almost exclusively to the youngest age group.
The length of stay per patient decreased in the last decade;
therefore, the rise in total PICU length of stay is chieﬂy
explained by an increase in the number of young children
starting with non-elective, invasive HMV.
Discussion
This observational study of 197 children on HMV rep-
resents one of the largest pediatric cohorts reported to
date, and the ﬁrst to describe experiences and trends in
applying HMV over a period of 3 decades. The most
striking change over time is the steep rise in the number
of children in whom HMV was being applied, particularly
during the last decade and in the youngest age group.
Table 2 Characteristics of the
patients who died Deceased patients
All patients Non-invasive Invasive
n = 43 n = 14 n = 29
Demographic data
Age (years) at start HMV (median, range) 13.2 (0.7–17.6) 15.2 (12.2–16.7) 12.2 (0.7–17.6)
Age (years) of death (median, range) 20.2 (1.2–37.1) 18.2 (13.9–29.9) 21.2 (1.2–37.1)
Time of ventilation in years (median, range) 7.5 (0.3–20.7) 4.2 (1.1–13.1) 8.8 (0.3–20.7)
Number of admission days post
HMV (median, range)
28.1 (2–254) 9.9 (2–21) 38.2 (2–254)
Start with HMV (n)
1979–1988 1 0 1
1989–1998 27 6 21
1999–2008 15 8 7
Underlying diseases (n)
Neuromuscular disorders 36 13 23
Central nervous system conditions 3 0 3
Chronic pulmonary or airway diseases 2 1 1
Miscellaneous 2 0 2
Location of death
Home 27 7 20
Hospital 16 7 9
Fig. 2 Number of children that started home mechanical ventila-
tion (HMV) depending on decade and age group
Table 3 The number of total PICU admission days as well as the
number of admission days before (pre-HMV) and following (post-
HMV) the day that invasive ventilation was started non-electively
on a home care ventilator, depending on decade and age group
All
patients
0–5
years
6–11
years
12–17
years
1979–1988
All patients (n)2 1 1 0
Total number of days 622 222 400 0
Pre-HMV 506 206 300 0
Post HMV 116 16 100 0
1989–1998
All patients (n)1 8 6 5 7
Total number of days 2,770 2,032 188 550
Pre-HMV 1,848 1,349 113 386
Post HMV 922 683 75 164
1999–2008
All patients (n)3 2 2 0 1 1 1
Total number of days 5,943 5,050 37 856
Pre-HMV 4,311 3,699 20 592
Post HMV 1,632 1,351 17 264
850Especially these children had very long stays in the PICU,
both before and after HMV was initiated.
There are several explanations for the increase in the
application of HMV in children. Presumably, the success
of HMV in adults has led to a greater awareness among
physicians involved in the care for children. Improve-
ments in medical health care, increased patient autonomy
and changing moral-ethical attitudes with respect to
treatment decisions may explain the growing number of
children admitted to and kept alive in the PICU [11].
Improvements in technology have made HMV not only an
alternative for death, but also succeeded in improving the
quality of life for most of these children; consequently
children are nowadays being referred for HMV more
frequently [12].
We found an escalating need for PICU beds, espe-
cially for the youngest children (Table 3), and
speciﬁcally these children consumed the most PICU
admission days. The retrospective nature of our study
limited an in-depth investigation of the reasons for these
prolonged stays. The pre-HMV length of stay probably
reﬂects the complexity of the medical condition in young
children: most of them were admitted after an acute
deterioration of their respiratory condition, often before
the diagnosis or prognosis of the underlying disorder was
made. This is underscored by the high incidence of non-
elective initiation of HMV in this group. We have the
impression that the most time post-initiation of HMV
was required for ﬁne-tuning ventilator settings, training
parents and organizing professional home care. In the
youngest children, with often less stable respiratory
conditions, these steps are often more difﬁcult and time-
consuming than in older children.
The long post-HMV period in the youngest age group
particularly raises our concern. Though lower per patient
than in the UK [13] and the US [14], it amounted to a total
of 1,351 post-HMV PICU days in the last decade, which
means blockade of one PICU bed for about 4 months for
each year in the last decade. During the last decade, a
discharge coordinator was introduced in our Center for
HMV, and efforts have been made to streamline the dis-
charge process in order to shorten PICU admission. As
shown in Table 3, this resulted in a decrease of post-HMV
days per patient compared to the previous decade, but
despite this, the total PICU length of stay rose consider-
ably because of an increase in young patients starting with
HMV. Since it is likely that this trend is going to con-
tinue, the need for PICU beds will probably continue to
rise as well. It could be worthwhile to establish designated
units outside the PICU for clinically stable children
requiring HMV [10]. Such a setting, which is less
stressful and more focused on rehabilitation than on acute
care, might not only be a better but also a cheaper and
safe alternative [15–18].
The amount of literature on trends in the application
of HMV in children is limited. We are aware of only
one other study covering the same time span, but this
study contained both children with and without HMV
and had different end points [8]. Other studies covered
a shorter time span [10, 19, 20] or a single time point
[7, 9, 21, 22], contained children with either invasive
[13, 20] or noninvasive HMV [23], or were mainly
focused on survival [15] or hospital admission days
[14]. In comparison to other studies, invasive HMV was
used with a comparable frequency (38 %) as in Mas-
sachusetts (49 %) or Italy (41 %), but markedly more
frequently than in Australia (22 %), the UK (23 %) or
Turkey (32 %) [7–9, 21, 24]. Invasive HMV is our ﬁrst
choice for the youngest children as they have already
been tracheotomized during their stay in the PICU and
need to keep a tracheostomy for the time being to
evacuate airway secretions. Moreover, noninvasive
ventilation may cause mid-facial retrusion if applied in
early childhood and is often poorly tolerated, particu-
larly when applied for 24 h per day [25]. Improvements
in interfaces for noninvasive HMV and new develop-
ments such as mechanical insufﬂation/exsufﬂation have,
however, caused a decline in tracheostomal ventilation,
also for very young patients [26, 27].
At the end of our study, 11 children (6 %) were
eventually weaned off of HMV. In other studies weaning
varied from 9 to 39 % [8, 10, 13, 14, 24]. Mortality was
considerable with 22 %, but nearly always related to the
underlying disorder, and comparable to the mortality of
7–32 % found in other cohorts [8, 10, 13, 14, 20, 24]. The
observation that most patients who died had used HMV
for several years strongly suggests that HMV prolonged
their lives.
Our retrospective study has several limitations. Being
a single center study, our results may not be automatically
applicable to other centers. However, the four Centers for
HMV in the Netherlands have always been comparable
with respect to their procedures, and we feel that our
results reﬂect the Dutch situation. As HMV in the Neth-
erlands is well organized, it is unclear to what extent our
ﬁndings can be extrapolated to patients in other countries.
Given the number of patients and time span involved we
consider our results relevant for providing trends with
regard to HMV in children and, thereby, for comparison
with other studies.
In conclusion, in the past 3 decades the number of
children, and particularly those aged 0–5 years, who
received HMV in our center increased substantially. This
was associated with an escalating need for pediatric inten-
sive care beds. If this trend continues, the establishment of
specialized facilities outside the PICU for clinically stable
children requiring HMV should be seriously considered.
Open Access This article is distributed under the terms of the
Creative Commons Attribution License which permits any use,
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author(s) and the source are credited.
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